Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

IntroductionClinical remission as a multicomponent treatment goal in severe asthma is being explored in clinical practice. This post hoc analysis used data from the REDES study to assess the proportion of patients with severe eosinophilic asthma achieving our multicomponent definitions of clinical r...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Frontiers Media S.A. 2023-04-01
Σειρά:Frontiers in Immunology
Θέματα:
severe asthma
remission
clinical outcomes
real-world
eosinophil biology
mepolizumab
Διαθέσιμο Online:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Διαδίκτυο

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Παρόμοια τεκμήρια